Deregulation of Interferon Signaling in Malignant Cells
Interferons (IFNs) are a family of cytokines with potent antiproliferative, antiviral, and immunomodulatory properties. Much has been learned about IFNs and IFN-activated signaling cascades over the last 50 years. Due to their potent antitumor effects in vitro and in vivo, recombinant IFNs have been...
Main Authors: | Leonidas C. Platanias, Surinder Kaur, Efstratios Katsoulidis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-02-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/2/406/ |
Similar Items
-
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
by: Candice Mazewski, et al.
Published: (2020-11-01) -
Type I and II Interferons in the Anti-Tumor Immune Response
by: Sarah E. Fenton, et al.
Published: (2021-03-01) -
Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads
by: Natacha Zanin, et al.
Published: (2021-01-01) -
IFN signaling: how a non-canonical model led to the development of IFN mimetics
by: Howard M Johnson, et al.
Published: (2013-07-01) -
Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons
by: Ronald L. Rabin, et al.
Published: (2021-02-01)